West Family Investments, Inc. Amgen Inc Transaction History

West Family Investments, Inc.

$321 Million
Q2 2024

A detailed history of West Family Investments, Inc. transactions in Amgen Inc stock. As of the latest transaction made, West Family Investments, Inc. holds 1,943 shares of AMGN stock, worth $626,054. This represents 0.19% of its overall portfolio holdings.

Number of Shares

1,943

Previous 2,026 4.1%

Holding current value

$626,054

Previous $576,000 5.38%

% of portfolio

0.19%

Previous 0.19%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $21,808 - $26,502	-83 Reduced 4.1%	1,943 $607,000
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $30,382 - $36,675	113 Added 5.91%	2,026 $576,000
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $1,022 - $1,153	-4 Reduced 0.21%	1,913 $550,000
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $86,148 - $106,955	-394 Reduced 17.05%	1,917 $515,000
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $495,177 - $585,538	2,311 New	2,311 $513,000
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $5,038 - $6,402	-22 Reduced 1.07%	2,033 $533,000
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $60,155 - $67,844	268 Added 15.0%	2,055 $463,000
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $102,435 - $113,992	444 Added 33.06%	1,787 $435,000
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $3,727 - $4,123	17 Added 1.28%	1,343 $324,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $263,714 - $301,797	1,326 New	1,326 $298,000
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $345,151 - $404,386	-1,626 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $379,801 - $421,361	1,626 New	1,626 $396,000

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Family Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Family Investments, Inc. with notifications on news.

Account

West Family Investments, Inc. Amgen Inc Transaction History